Significant Ownership of Advent Life Sciences LLP
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Advent Life Sciences LLP focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/Rajesh Parekh, Ph.D. - General Partner of Advent Life Sciences LLP
- Manager location
- London, United Kingdom
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Advent Life Sciences LLP and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from Advent Life Sciences LLP
Significant Ownership of Advent Life Sciences LLP
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| AURA | Aura Biosciences, Inc. | Common Stock, par value $0.00001 per share | 3.3% | $11,768,148 | 2,071,857 | Rajesh Parekh, Ph.D. | 13 Feb 2026 | ||
| AFIB | Acutus Medical, Inc. | Common Stock, par value $0.001 per share | 0% | $0 | 0 | Advent Life Sciences LLP | 09 Jul 2025 |
Schedules 13D/G Reported by Advent Life Sciences LLP:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.